telephone number icon 844.997.3231

Father’s Day Sale! Up to 50% OFF! Hurry—Sale Ends Fri, Jun 5 Save Now >>

Get Up to 50% OFF Sitewide—Father’s Day Sale

OFFER ENDS Fri, Jun 5

00

Days
:

00

Hrs
:

00

Mins
:

00

Secs
Claim Offer

Few clinical services have moved as fast as medical weight loss. The arrival of effective GLP-1 medications, paired with an obesity epidemic that now affects more than one in three American adults, has created sustained patient demand that most practices are not equipped to meet. For physicians, nurse practitioners, and physician assistants, that gap is an opportunity — to add a service that patients are actively searching for, that fits inside an existing practice, and that operates almost entirely on a cash-pay basis.

This guide is written for providers thinking about offering medical weight loss. It covers the practical questions — who can do this, what training you need, what the clinical and business setup actually looks like — and links throughout to deeper resources in our medical weight loss library. It is professional education, not legal or medical advice; verify everything against your state board, your malpractice carrier, and current FDA labeling.

The short version: Decide which services you will offer, get properly trained in obesity medicine and weight-loss pharmacology, build clean clinical workflows and documentation, price it as a cash-pay program, and stay compliant with DEA and state rules for any controlled substances. The fastest, lowest-risk way to do all of this well is structured training.

Why add medical weight loss now

The market context is unusually favorable. Obesity is now formally recognized as a chronic, relapsing, multifactorial disease rather than a lifestyle failing, and patients increasingly seek it out as a medical condition to be treated. Worldwide, more than 40% of adults attempt to lose weight every year, and the weight-loss industry is projected to be a multi-hundred-billion-dollar market. The GLP-1 medications have, for the first time, given clinicians an FDA-approved, evidence-backed pharmacologic tool for a condition where durable options were historically scarce.

Just as important for a practice owner: medical weight loss is recurring by nature. Obesity is managed over time, not cured in a single visit, so patients return for follow-up, titration, and monitoring. That makes it one of the few services that generates a predictable, ongoing relationship rather than a one-off encounter — and it slots naturally into primary care, family medicine, internal medicine, OB/GYN, aesthetics, and functional-medicine practices alike. You are not opening a new clinic so much as activating demand that is already walking through your door.

Who can offer it

Medical weight loss is delivered by licensed prescribers — MDs, DOs, nurse practitioners, and physician assistants — working within their state scope of practice and any collaborative or supervisory requirements. The clinical bar is real: this is medicine, involving prescription pharmacology, comorbidity management, and ongoing monitoring, not a retail diet program.

Two scope nuances matter from day one. First, prescribing controlled substances such as phentermine requires a current DEA registration that permits the relevant schedule, and several states impose specific rules on using scheduled drugs for weight loss. Second, the practice of nutrition itself is regulated in some states and may be reserved to registered dietitians or licensed nutritionists — so if your program includes formal diet prescribing, confirm with your state board and malpractice carrier where that line sits. Knowing your own state's rules before you see the first patient is non-negotiable.

Getting trained — the key step

There is no single mandated certificate to offer medical weight loss, but that is precisely why training is the step that separates a credible program from a liability. Obesity medicine is a distinct clinical field with its own pharmacology, patient-selection criteria, contraindications, and rapidly changing evidence base. The science, as Empire's faculty put it, changes almost daily — competence comes from a structured foundation plus a habit of keeping current.

The most efficient way to build that foundation is a dedicated course. Empire Medical Training's Physician Medical Weight Loss Training is built for exactly this: it teaches the GLP-1 biology, the full medication menu and how to choose between agents, body composition assessment, nutrition and behavioral counseling, and — critically — the business and compliance setup most clinical training ignores. It is CME-accredited and designed to take you from "interested" to "open for patients."

Get trained, then open your program

Empire Medical Training's Physician Medical Weight Loss Training is the fastest, lowest-risk path to launching. You will learn the full clinical protocols, the complete medication toolkit, patient selection and monitoring, and the practice-setup and compliance details that turn knowledge into a running program. Taught by board-certified physicians, CME-accredited, in person or via livestream.

Explore the Medical Weight Loss Course →

The clinical toolkit, at a glance

A medical weight loss program is more than a prescription pad. It rests on four pillars — assessment, the medication menu, injectable adjuncts, and nutrition and behavior — each of which is taught in depth in the course. Here is the high-level map.

Assessment and tracking

You cannot manage what you cannot measure. Programs use objective measures — BMI, waist circumference and waist-to-hip ratio, and where available bioelectric impedance or other body composition methods — to establish a baseline, set a documented weight-loss goal, and follow progress over time. Each tool has trade-offs (BMI does not distinguish muscle from fat; impedance is convenient but shifts with hydration), which is why body composition assessment is its own discipline. A baseline history, physical, and labs also screen for contraindications and the medical sequelae of obesity that must be documented.

The medication menu

The pharmacologic toolkit spans several mechanisms: appetite suppressants like phentermine, combination agents such as phentermine-topiramate and naltrexone-bupropion, the fat-absorption inhibitor orlistat, and the GLP-1 receptor agonists that now dominate the field. Choosing among them depends on the patient's history, comorbidities, contraindications, and tolerability — there is no one-size-fits-all first line. Our overview of weight loss medications maps the full menu, and GLP-1 medications for weight loss covers the class driving most demand today. Exact dosing and titration schedules are taught in the course.

Injectable adjuncts, nutrition, and behavior

Many programs add injectable adjuncts — lipotropic (MIC) injections and similar — and most build in nutrition and behavioral support, whether through an in-house dietitian, health coaches, or trained nursing staff. Be evidence-honest here: some popular add-ons are weakly supported. B12 injections, for example, do not produce weight loss in non-deficient patients, and older modalities like HCG lack convincing evidence. Diet and exercise remain the foundation every medication is layered on top of, with adequate protein and resistance training to protect lean mass as weight comes off — itself a frequently missed half of the job.

Program design and pricing

Before you see patients, decide what your program actually is. Empire's faculty frame the setup as a series of concrete choices: which services you will provide (medical assessment, prescribing, in-office labs or EKG, dispensing of medications, meal replacements, supplements, nutritional counseling); whether you will employ or partner with a dietitian, nutritionist, or health coach; and whether you train your existing nursing staff for counseling. Each decision shapes your workflow, your staffing, and your margins.

Pricing follows from the model. Because obesity treatment is essentially a cash-pay service (more on why below), you set program fees rather than chase reimbursement — typically structured as an initial consultation plus recurring follow-up visits, with medications, labs, and any meal replacements or supplements priced separately. The honest way to build pricing is from your own costs upward: drug acquisition (you can sanity-check generic prices against tools like GoodRx), lab costs, staff time, and overhead. For a fuller treatment of the variables that move the number, see cost of medical weight loss. We deliberately do not publish price or income figures — build a model that reflects your market.

Compliance and sourcing

This is the area where good programs protect themselves and weak ones get into trouble. Three things deserve your attention up front.

Controlled substances. Phentermine is a Schedule IV drug, and other agents may be scheduled as well. Prescribing them requires a DEA registration covering the relevant schedule, awareness of state-specific limits (some states cap weight-loss prescribing at a defined period; at least one prohibits certain schedules for weight loss entirely), and disciplined documentation — a comprehensive exam, a clearly stated weight-loss goal in the chart, and accurate records. Never dispense or prescribe without the basic patient encounter documented.

GLP-1 sourcing and compounding. FDA-approved GLP-1 medications are sourced through standard pharmacy channels by prescription. Compounded GLP-1 products exist largely because of past drug-shortage dynamics, but they occupy a far more complicated and shifting regulatory position, and the FDA has raised concerns about them. The honest guidance is caution: compounded product is not equivalent to the approved drug, sourcing and quality vary, and the rules continue to change. If you dispense or compound anything in-house, use reputable pharmacies, label clearly with date and patient name, and track lot and expiration.

Documentation and scope. Beyond controlled substances, document the medical rationale for treatment, screen contraindications before the first prescription, and respect the state nutrition-practice rules noted earlier. The course covers the compliance framework in detail; treat it as core infrastructure, not paperwork.

Workflow and retention

Operationally, a strong program is built around the follow-up, not the first visit. The typical patient journey is: intake and baseline assessment, medication selection and slow, tolerated titration, then scheduled return visits to monitor progress, manage side effects, and adjust. Because GLP-1 outcomes hinge on tolerability — escalate slowly, step back rather than stop when GI symptoms appear — the cadence of follow-up is the clinical strategy, and it is also what sustains the practice economically.

Retention is helped by structure patients can feel: objective progress tracking, behavioral support and nutrition tools (many practices use patient-facing tracking apps, some private-labeled to the practice), and clear counseling about what to expect — including that weight loss plateaus and that discontinuing GLP-1 therapy commonly leads to regain. Setting those expectations up front, rather than after a patient calls discouraged, is one of the highest-leverage things a program does.

The business case, honestly

The most compelling structural fact about medical weight loss is its payment model: insurers currently provide little to no coverage for obesity or weight-loss treatment. For patients that is a real barrier; for providers it means the service is predominantly cash-pay, which removes the friction, denials, and write-downs of insurance billing and lets you set transparent program pricing. Combined with the recurring, ongoing nature of obesity care, that makes weight loss one of the more durable cash-pay revenue lines a clinic can add.

It is worth being candid about the flip side. As Empire's faculty note, it is very difficult to build a sustainable revenue stream on diet counseling alone — education is time-intensive and hard to monetize without the medical and pharmacologic components. The viable model layers assessment, prescribing, and follow-up into a structured program. We do not publish income figures or guarantees, and you should be skeptical of anyone who does. What we can say plainly is that demand is high, the payment model is clean, and the service compounds over time — the economics reward providers who run it as a real clinical program rather than a side offering.

Your fastest path to launch

You can assemble all of this piecemeal, but the efficient route is structured training that hands you the clinical protocols, the medication decision-making, the assessment tools, and the practice-and-compliance playbook in one place. That is exactly what Empire's Physician Medical Weight Loss Training is designed to deliver — taught by board-certified physicians including Dr. Betsy Greenleaf, Empire's Director of Anti-Aging. Get certified, then open your program.

Starting a medical weight loss practice: frequently asked questions

How do I start a medical weight loss practice?

Start by deciding which services you will offer (medical assessment, prescribing, body composition testing, nutrition counseling, meal replacements or supplements), then get trained in obesity medicine and weight-loss pharmacology, build your clinical workflow and documentation, set cash-pay pricing, and ensure compliance with DEA and state rules for any controlled substances. Most providers add medical weight loss to an existing practice rather than opening a standalone clinic. Empire Medical Training's medical weight loss course walks providers through the clinical and business setup step by step.

What training is required to offer medical weight loss?

There is no single mandated certificate, but obesity medicine is a distinct clinical field and competent prescribing requires structured education. Providers should understand GLP-1 biology, the full medication menu and contraindications, patient selection, body composition assessment, nutrition and behavioral counseling, and the regulatory rules around controlled substances and compounded products. Empire Medical Training offers a CME-accredited Physician Medical Weight Loss Training course covering both the clinical science and the practice setup.

Who can prescribe weight loss medications?

Licensed prescribers — physicians (MD/DO), nurse practitioners, and physician assistants — can prescribe FDA-approved weight-loss medications within their state scope of practice and collaborative requirements. Controlled substances such as phentermine additionally require a current DEA registration that permits the relevant schedule, and several states impose specific restrictions on prescribing scheduled drugs for weight loss. Always verify your state board rules before prescribing.

Is a medical weight loss practice profitable?

Medical weight loss is overwhelmingly a cash-pay service, because insurers currently provide little to no coverage for obesity treatment. That makes it a predictable, recurring revenue line for many practice types, since patients are seen on an ongoing basis rather than once. Profitability depends on patient volume, your pricing, drug and lab sourcing costs, and staff model. We do not publish income claims; build a realistic model around your own costs and market.

How do I source GLP-1 medications?

FDA-approved GLP-1 medications are sourced through standard pharmacy channels by prescription. Compounded GLP-1 products exist in part because of past drug-shortage dynamics, but they sit in a more complicated and shifting regulatory position, and the FDA has raised concerns about compounded GLP-1 products. Any provider considering compounded sourcing must understand current FDA rules and use reputable pharmacies. Sourcing and compliance are covered in Empire's medical weight loss training.